Skip to content
★ Sign in to follow
Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. logo

Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. Stock: price and insider trades · China

达嘉维康

CN·Mcap CN¥2BHealth Care

Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd.: what insiders have been doing

Every trade that managers of Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. No insider at Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 28 October 2025.

Over the whole record (from 2022), the tally stands at no purchases and 6 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€3M
6 ops. · all time

Who traded when

BuySale
钟雪松1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 25,238 of 26,914 companies
17.2
score / 100
Value
15
Quality
20
FCF yld-13%
Earn yld-12%
EV/EBITDA·
ROE-13%
Gross mgn18%
Net mgn-4.7%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥9.70
Analyst consensus
·
Income statement
RevenueCN¥5.1B
Gross profitCN¥936.3M18% margin
EBITDACN¥42.8M1% margin
Net income-CN¥242.5M-4.6% margin
Valuation
P/Book1.3x
Beta0.63
Balance sheet & cash
Market capCN¥2B
Total debtCN¥3.7B
Free Cash Flow-CN¥253.8M
Debt / Equity221%
Profitability & ownership
ROE-12.7%
ROA1.0%
% insiders50.7%
% institutions9.5%
Last declaration on 28 October 2025
Declarations6 total
  • ▼
    董事Executives
    381,286 CNY7SZSE
    31,100 shares1.6% of flowA股XSHESZSE:173000009689581600
  • ▼
    董事Executives
    3M CNY9SZSE
    200,000 shares15.7% of flowA股XSHESZSE:173000006337140900
  • ▼
    董事Executives
    6M CNY10SZSE
    350,000 shares26.2% of flowA股XSHESZSE:173000006255618300
  • ▼
    董事Executives
    2M CNY8SZSE
    150,000 shares10.8% of flowA股XSHESZSE:173000006199919200
  • ▼
    董事Executives
    2M CNY8SZSE
    100,000 shares7.0% of flowA股XSHESZSE:173000006178543520
  • ▼
    董事Executives
    9M CNY11SZSE
    600,000 shares38.8% of flowA股XSHESZSE:173000006161565060

6 of 6 declarations

About Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd.

Dajia Weikang is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and commercialization of innovative pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations